Get the Stockscreener App
0.8953
1.93%
-0.0176
Oragenics Inc stock is traded at $0.8953, with a volume of 47,399.
It is down -1.93% in the last 24 hours and down -34.65% over the past month.
Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$0.9129
Open:
$0.94
24h Volume:
47,399
Relative Volume:
0.36
Market Cap:
$3.73M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.1048
EPS:
-8.54
Net Cash Flow:
$-8.25M
1W Performance:
-20.06%
1M Performance:
-34.65%
6M Performance:
-84.46%
1Y Performance:
-88.97%
1-Day Range:
$0.82
$0.94
1-Week Range:
$0.82
$1.13
52-Week Range:
$0.82
$18.90
Oragenics Inc Stock (OGEN) Company Profile
Name
Oragenics Inc
Sector
Industry
Phone
813-286-7900
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Compare OGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
0.8953 | 3.81M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oragenics Inc Stock (OGEN) Latest News
Can Oragenics Inc. stock resist broad market declinesQuarterly Profit Report & AI Optimized Trade Strategies - newser.com
Will Oragenics Inc. stock see valuation expansionMarket Performance Recap & Stock Timing and Entry Methods - newser.com
How Oragenics Inc. stock performs in interest rate cycles2025 Growth vs Value & Daily Momentum Trading Reports - newser.com
Combining machine learning predictions for Oragenics Inc.Market Trend Summary & Fast Momentum Stock Entry Tips - newser.com
Why Oragenics Inc. stock is a strong buy callDip Buying & Short-Term Trading Alerts - newser.com
Will Oragenics Inc. stock benefit from infrastructure spendingQuarterly Profit Summary & Fast Momentum Entry Tips - newser.com
Will Oragenics Inc. stock maintain momentum in 2025Weekly Trade Report & Verified Chart Pattern Signals - newser.com
What technical charts say about Oragenics Inc. stock2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Oragenics Inc. stock outlook for YEARQuarterly Portfolio Review & Breakout Confirmation Trade Signals - newser.com
Full technical analysis of Oragenics Inc. stockJuly 2025 Levels & Safe Capital Investment Plans - newser.com
Why hedge funds are buying Oragenics Inc. stock2025 Earnings Surprises & Verified Entry Point Signals - newser.com
Sector ETF performance correlation with Oragenics Inc.Gap Up & Breakout Confirmation Trade Signals - newser.com
Is Oragenics Inc. stock cheap at current valuationMarket Growth Report & Weekly High Potential Stock Alerts - newser.com
Why Oragenics Inc. stock appears on watchlistsJuly 2025 Rallies & Daily Chart Pattern Signals - newser.com
Does Oragenics Inc. show high probability of reboundJuly 2025 Opening Moves & Consistent Income Trade Ideas - newser.com
Is Oragenics Inc. stock a top momentum playEarnings Performance Report & Risk Managed Investment Entry Signals - newser.com
What MACD trends signal for Oragenics Inc. stock2025 Market Sentiment & Daily Price Action Insights - newser.com
Analyzing Oragenics Inc. with multi timeframe chartsJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
Is Oragenics Inc. stock near bottom after declineRate Hike & Consistent Income Trade Ideas - newser.com
Can you recover from losses in Oragenics Inc.Trade Ideas & Daily Profit Maximizing Tips - newser.com
Will Oragenics Inc. stock outperform value stocks2025 Performance Recap & Real-Time Chart Breakout Alerts - newser.com
Heatmap analysis for Oragenics Inc. and competitors2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Is Oragenics Inc. trending in predictive chart modelsJuly 2025 Decliners & AI Optimized Trading Strategy Guides - newser.com
Why Oragenics Inc. stock is seen as undervaluedBull Run & Safe Capital Growth Stock Tips - newser.com
Oragenics Inc Stock (OGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):